Conyers advises Golden Meditech Holdings Limited in connection with its HK$425 million privatisation by way of a scheme of arrangement and its subsequent delisting from the Hong Kong Stock Exchange

Oct 2020

Conyers acted as Cayman legal counsel to Golden Meditech Holdings Limited (“Golden Meditech”) on the privatisation of Golden Meditech by way of a scheme of arrangement (under Section 86 of the Companies law) and its subsequent delisting from the Hong Kong Stock Exchange.

Headquartered in Beijing, Golden Meditech provides medical devices and healthcare services such as cord blood stem cells storage and hospital management.

Partner Richard Hall, Counsel Angie Chu and Associate Ryan McConvey of Conyers’ Hong Kong office, and Partner Ben Hobden of Conyers’ Cayman Islands office advised on the matter working alongside Minter Ellison.